$OMDA

Gracey Craig sold $14K of OMDA

Gracey Craig (Chief Accounting Officer) sold 644 shares of Omada Health, Inc. (OMDA) at $21.73 on 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Sep 11, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosed sale is routine and does not alter the company's fundamentals.

02

Market read

Minor insider sale with negligible market impact.

03

What to watch

Potential upcoming earnings or product announcements could make any insider activity more material.

Relevance 2/10Novelty 4/10Timing: filing after market close on 2026-09-11

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of confidence or distress.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Chief Accounting Officer Gracey Craig sold 644 shares for $13,995 via a 10b5-1 plan, reducing her stake to 14,412 shares.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

Sale amount <$15K and insider is a C-level officer; market typically discounts such minor disposals.

Market effects

No broader sector impact; Omada operates in digital health niche.

None; company is US‑based with limited regional exposure.

Insignificant on a global scale.

Counterpoint

If the insider had a larger stake, the sale could signal concerns, but the tiny size suggests routine liquidity need.

Key entities

  • Omada Health, Inc.

    US‑listed digital health company (ticker OMDA).

  • Gracey Craig

    Chief Accounting Officer of Omada Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch